The novel therapy of this peptide represents a major breakthrough in the management of diabetes mellitus type 2. Distinct from existing medications, tirzepatide targets dual pathways – the GLP-1 hormone and GIP – https://tirzepatide-peptide581759.qodsblog.com/42171615/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment